{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zhao Y"],"funding":["National Natural Science Foundation of China"],"pagination":["146"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11494863"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["19(1)"],"pubmed_abstract":["<h4>Background</h4>This study aims to assess the clinical efficacy of elective neck irradiation (ENI) in patients with esthesineuroblastoma (ENB), a rare malignant neoplasm, who are clinically node-negative.<h4>Methods</h4>We conducted a retrospective analysis of 178 patients newly diagnosed with ENB at our institution between 2009 and 2021. Propensity score matching (PSM) was employed to compare node-negative patients treated with and without ENI. We extensively examined survival outcomes and treatment failure.<h4>Results</h4>Of the 178 participants, 149 (83.7%) were lymph node-negative and staged in Modified Kadish A-C. 96 patients underwent ENI treatment, while 53 did not. At baseline, patients who received ENI differed from those who did not in terms of radiotherapy technique, staging,"],"journal":["Radiation oncology (London, England)"],"pubmed_title":["The value of elective neck irradiation in management of esthesioneuroblastoma: a retrospective study based on propensity score matching."],"pmcid":["PMC11494863"],"funding_grant_id":["82303420"],"pubmed_authors":["Yan L","Zhu Y","Li R","Wang X","Zhao Y"],"additional_accession":[]},"is_claimable":false,"name":"The value of elective neck irradiation in management of esthesioneuroblastoma: a retrospective study based on propensity score matching.","description":"<h4>Background</h4>This study aims to assess the clinical efficacy of elective neck irradiation (ENI) in patients with esthesineuroblastoma (ENB), a rare malignant neoplasm, who are clinically node-negative.<h4>Methods</h4>We conducted a retrospective analysis of 178 patients newly diagnosed with ENB at our institution between 2009 and 2021. Propensity score matching (PSM) was employed to compare node-negative patients treated with and without ENI. We extensively examined survival outcomes and treatment failure.<h4>Results</h4>Of the 178 participants, 149 (83.7%) were lymph node-negative and staged in Modified Kadish A-C. 96 patients underwent ENI treatment, while 53 did not. At baseline, patients who received ENI differed from those who did not in terms of radiotherapy technique, staging,","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Oct","modification":"2025-04-04T19:45:25.146Z","creation":"2025-04-04T19:45:25.146Z"},"accession":"S-EPMC11494863","cross_references":{"pubmed":["39434155"],"doi":["10.1186/s13014-024-02539-x"]}}